Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.
Publication/Presentation Date
5-2012
Published In/Presented At
Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.. JCO 30, 2032-2032(2012).
DOI:10.1200/jco.2012.30.15_suppl.2032Disciplines
Medicine and Health Sciences | Oncology
Department(s)
Department of Radiation Oncology
Document Type
Article
COinS